IHT Wealth Management, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
IHT Wealth Management, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$57,600
+2.3%
28,800
+7.5%
0.00%0.0%
Q1 2023$56,280
+53.3%
26,8000.0%0.00%
+50.0%
Q4 2022$36,716
+59.6%
26,800
+21.8%
0.00%0.0%
Q3 2022$23,000
-4.2%
22,0000.0%0.00%0.0%
Q2 2022$24,000
-4.0%
22,000
-8.3%
0.00%0.0%
Q1 2022$25,000
+25.0%
24,0000.0%0.00%
+100.0%
Q4 2021$20,000
-54.5%
24,000
-27.7%
0.00%
-75.0%
Q3 2021$44,00033,2000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$2,513,0000.04%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$27,0000.02%
MEITAV INVESTMENT HOUSE LTD 244,332$256,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$139,0000.00%
IHT Wealth Management, LLC 22,000$23,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BANK OF AMERICA CORP /DE/ 3,027$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DAVENPORT & Co LLC 22,000$23,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders